- Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum2016 | First Faculty of Medicine, Second Faculty of Medicine
- Komentář2021 | First Faculty of Medicine
- Serous tubal intraepithelial carcinoma2018 | First Faculty of Medicine
- Olaparib - the first PARP inhibitor in the treatment of malignant tumors2015 | First Faculty of Medicine
- PARP inhibitor olaparib and anti-VEGF bevacizumab - targeted treatment and efforts to improve the outcome of patients with advanced tuboovarian cancer2020 | Faculty of Medicine in Pilsen